Comparing abatacept to Adalimumab, Etanercept and Infliximab As First Or Second Line Agents in Patients With Rheumatoid arthritis: Experience From the rhumadata® Clinical Database and Registry

被引：0
|
作者：
Choquette, Denis [1 ]
Sauvageau, Diane [1 ]
Bessette, Louis [2 ]
Haraoui, Boulos [1 ]
Pelletier, Jean Pierre [1 ]
Raynauld, Jean-Pierre [1 ]
Villeneuve, Edith [1 ]
Coupal, Louis [1 ]
机构：
[1] Inst Rhumatol Montreal, Montreal, PQ, Canada
[2] Ctr Hosp Univ Quebec, Ste Foy, PQ, Canada
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
430
引用
收藏
页码：S186 / S186
页数：1
相关论文
共 50 条
  • [1] Comparing Abatacept to Adalimumab, Etanercept and Infliximab as First or Second Line Agents in Patients with Rheumatoid Arthritis. Experience from the RHUMADATA® Clinical Database and Registry
    Coupal, Louis
    Haraoui, Boulos
    Bessette, Louis
    Raynauld, Jean-Pierre
    Pelletier, Jean-Pierre
    Massicotte, Frederic
    Remillard, Marie-Anais
    Sauvageau, Diane
    Villeneuve, Edith
    Choquette, Denis
    [J]. JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1314 - 1314
  • [2] COMPARING ABATACEPT TO ADALIMUMAB, ETANERCEPT AND INFLIXIMAB AS FIRST OR SECOND LINE AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS. EXPERIENCE FROM THE RHUMADATA® CLINICAL DATABASE AND REGISTRY
    Fortin, I.
    Choquette, D.
    Bessette, L.
    Haraoui, B.
    Pelletier, J. -P.
    Raynauld, J. P.
    Remillard, M-A
    Sauvageau, D.
    Villeneuve, E.
    Coupal, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 273 - 274
  • [3] Comparing Abatacept to Adalimumab, Etanercept and Infliximab As First Line Agents in Patients with Rheumatoid Arthritis. Experience from the Rhumadata® Clinical Database and Registry.
    Choquette, Denis
    Bessette, Louis
    Fortin, Isabelle
    Haraoui, Boulos
    Pelletier, Jean Pierre
    Raynauld, Jean-Pierre
    Remillard, Marie-Anais
    Sauvageau, Diane
    Villeneuve, Edith
    Coupal, Louis
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S676 - S677
  • [4] USE OF ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM THE RHUMADATA DATABASE: EXPERIENCE AS FIRST OR SECOND LINE AGENT COMPARED WITH ADALIMUMAB AND ETANERCEPT
    Choquette, D.
    Sauvageau, D.
    Haraoui, B.
    Pelletier, J. -P.
    Raynauld, J. -P.
    Villeneuve, E.
    Coupal, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 449 - 449
  • [5] Comparing Adalimumab and Etanercept As First Line Agents In Patients With Psoriatic Arthritis. Data From The Rhumadata® Clinical Database and Registry
    Hoa, Sabrina
    Choquette, Denis
    Bessette, Louis
    Sauvageau, Diane
    Haraoui, Boulos
    Pelletier, Jean Pierre
    Raynauld, Jean-Pierre
    Villeneuve, Edith
    Coupal, Louis
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S145 - S145
  • [6] Use Of Rituximab As Second Line Biologic Agent Compared With Adalimumab, Etanercept and Infliximab In Patients With Rheumatoid Arthritis. A Report From The Rhumadata® Clinical Database and Registry
    Bessette, Louis
    Choquette, Denis
    Sauvageau, Diane
    Haraoui, Boulos
    Pelletier, Jean Pierre
    Raynauld, Jean-Pierre
    Villeneuve, Edith
    Coupal, Louis
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S187 - S187
  • [7] Retention on Adalimumab, Etanercept, Golimumab and Infliximab in Two Eras - Experience of Patients with Rheumatoid Arthritis from a Real-World Database RHUMADATA®
    Choquette, Denis
    Bessette, Louis
    Coupal, Louis
    Garces, Kirsten
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [8] Infliximab, Etanercept, and Adalimumab switching in patients with rheumatoid arthritis in the CORRONA database
    Dabbous, O.
    Kremer, J.
    Rambharose, J.
    El Taha, M.
    Reed, G.
    Tang, B.
    Thomson, H.
    Domdey, A.
    Rahman, M.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 : 42 - 42
  • [9] Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry
    Denis Choquette
    Louis Bessette
    Evo Alemao
    Boulos Haraoui
    Roelien Postema
    Jean-Pierre Raynauld
    Louis Coupal
    [J]. Arthritis Research & Therapy, 21
  • [10] Retention rates of adalimumab, etanercept and infliximab as first and second-line biotherapy in patients with rheumatoid arthritis in daily practice
    Frazier-Mironer, Aline
    Dougados, Maxime
    Mariette, Xavier
    Cantagrel, Alain
    Deschamps, Veronique
    Flipo, Rene Marc
    Logeart, Isabelle
    Schaeverbeke, Thierry
    Sibilia, Jean
    Le Loet, Xavier
    Combe, Bernard
    [J]. JOINT BONE SPINE, 2014, 81 (04) : 352 - 359
12345